| Product name: |
Eurican L4 |
| Active substance: |
Leptospira interrogans inact., séroskupina a sérovar Canicola kmen 16070, Leptospira interrogans inact., séroskupina a sérovar Icterohaemorrhagiae kmen16069, Leptospira interrogans inact., séroskupina a sérovar Grippotyphosa kmen Grippo Mal 1540, Leptospira interrogans inact., séroskupina Australis, sérovar Bratislava |
| Target tribe: |
psi |
| Drug form: |
Injekční suspenze |
| Registration date: |
31. 3. 2023 |
| Registration number: |
EU/2/23/293/001-002 |
| Verdict holder: |
Boehringer Ingelheim Vetmedica, GmbH
Binger Strasse 173
Ingelheim am Rhein 55216
Phone: , Fax:
Email: |
| ATC vet. code: |
QI07AB - Leptospira vaccine |
| Pharmacotherapeutic group: |
Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia vaccines) |
| Narcotics: |
NO |
| Indication restriction: |
NO |
| Withdrawal period: |
|
| Procedure type: |
Centralised |
Table of active package codes| Package code | Size | Package type | Material | Identification code | EU number | Issue |
|---|
| 9910248 | 10 x 1 ml | injekční lahvička | sklo | - | - | Na předpis | | 9910249 | 50 x 1 ml | injekční lahvička | sklo | - | - | Na předpis |
| Package code | Size | Package type | Material | Identification code | EU number | Issue |
|---|
|
Authorisation & Approval 
